Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.
2.

Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi.

Feng J, Zhang S, Shi W, Zubcevik N, Miklossy J, Zhang Y.

Front Med (Lausanne). 2017 Oct 11;4:169. doi: 10.3389/fmed.2017.00169. eCollection 2017.

4.

A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library.

Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y.

Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016.

5.

Cimetidine as a novel adjunctive treatment for early stage Lyme disease.

Shemenski J.

Med Hypotheses. 2016 Apr 9. pii: S0306-9877(16)30007-X. doi: 10.1016/j.mehy.2016.03.015. [Epub ahead of print]

PMID:
27107653
6.

Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime.

Feng J, Weitner M, Shi W, Zhang S, Zhang Y.

Front Microbiol. 2016 Feb 10;7:62. doi: 10.3389/fmicb.2016.00062. eCollection 2016.

7.

Effectiveness of Stevia Rebaudiana Whole Leaf Extract Against the Various Morphological Forms of Borrelia Burgdorferi in Vitro.

Theophilus PA, Victoria MJ, Socarras KM, Filush KR, Gupta K, Luecke DF, Sapi E.

Eur J Microbiol Immunol (Bp). 2015 Nov 12;5(4):268-80. doi: 10.1556/1886.2015.00031. eCollection 2015 Dec.

8.

Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.

Feng J, Shi W, Zhang S, Zhang Y.

Emerg Microbes Infect. 2015 Aug;4(8):e51. doi: 10.1038/emi.2015.51. Epub 2015 Aug 19. No abstract available. Erratum in: Emerg Microbes Infect. 2015;4:e56.

9.

Persister Development by Borrelia burgdorferi Populations In Vitro.

Caskey JR, Embers ME.

Antimicrob Agents Chemother. 2015 Oct;59(10):6288-95. doi: 10.1128/AAC.00883-15. Epub 2015 Jul 27.

10.

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.

Feng J, Wang T, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y.

Emerg Microbes Infect. 2014 Jul;3(7):e49. doi: 10.1038/emi.2014.53. Epub 2014 Jul 2.

11.

Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.

Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K.

Antimicrob Agents Chemother. 2015 Aug;59(8):4616-24. doi: 10.1128/AAC.00864-15. Epub 2015 May 26.

12.

Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.

Feng J, Auwaerter PG, Zhang Y.

PLoS One. 2015 Mar 25;10(3):e0117207. doi: 10.1371/journal.pone.0117207. eCollection 2015.

13.

Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.

Feng J, Weitner M, Shi W, Zhang S, Sullivan D, Zhang Y.

Antibiotics (Basel). 2015 Sep 16;4(3):397-410. doi: 10.3390/antibiotics4030397.

Supplemental Content

Loading ...
Support Center